Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Cinclus Pharma Holding AB (publ)
Sponsor

Cinclus Pharma Holding AB (publ)

Sweden Kungsbron 1, 111 22 Stockholm, Sweden

About the sponsor

Clinical activity is centered on GERD and erosive esophagitis, with emphasis on healing, maintenance of healing, and symptom-related disease control in patients with reflux-related mucosal injury.

  • Erosive gastroesophageal reflux disease
  • Erosive esophagitis due to GERD
  • Healing of reflux-associated esophageal lesions
  • Maintenance of mucosal healing

The sponsor’s research in this area reflects a strong focus on upper gastrointestinal disorders managed through acid suppression and mucosal protection.

About Specializations

Cinclus Pharma Holding AB (publ) runs clinical trials in conditions such as Gastrooesophageal reflux disease, Erosive oesophagitis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Gastrooesophageal reflux disease+1

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Lansoprazole
  • Sponsor:Cinclus Pharma Holding AB (publ)

Gastrooesophageal reflux disease+1

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Lansoprazole
  • Sponsor:Cinclus Pharma Holding AB (publ)

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.